Expanded access to cutting edge car T-Cell Therapy
Access to a cutting edge and potentially curative cancer therapy will be expanded for patients with particular forms of lymphoma, following a positive recommendation from the medical experts on the Medical Services Advisory Committee (MSAC). Between 200 and 250 additional cancer patients with Diffuse Large B Cell Lymphoma, Transformed Follicular Lymphoma and Primary Mediastinal B…